KYORIN Pharmaceutical Co., Ltd.

News
Contact Us
Sitemap

日本語
English

Site Search

ビットカジノ入金 and
About Kyorin
KYORIN Holdings, Inc. has merged its wholly owned subsidiary KYORIN Pharmaceutical. Co., Ltd and has changed its trade name to “KYORIN Pharmaceutical. Co., Ltd.” on April 2023.
ビットカジノess Plan “Vision
Investor Relations
This section provides information on the ビットカジノ登録ボーナスsion, medium-term business plan, financial and performance results, IR library and stock.
ビットカジノ登録ボーナスarmony
Sustainability
Following our corperate philosophy, Kyorin Group is working to contribute to society’s continuous development and our sustainable growth by fulfilling our social responsibility through we business activities with ビットカジノ登録ボーナス as our core business.
R&D
R&D
A large number of unmet medical needs are still present in the world. This section provides information on our initiatives for drug discovery, and development pipeline.

Site Search

日本語
English

ビットカジノアプリ depreciation,Financial

ビットカジノ入金 and

ビットカジノess Plan “Vision

ビットカジノ登録ボーナスarmony

R&D

ビットカジノ入金ボーナス
ビットカジノアプリ
Site Map

News

Top
News
2025年

ビットカジノスロット Governance,Corporate

January 14, 2025: KYORIN and BIODOL Enter Into Option Agreement for Novel Pain Treatment

1

Archive

2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006

Go to page top Top

ビットカジノアプリ depreciation,FinancialTop

ビットカジノ入金 and

ビットカジノess Plan “Vision

ビットカジノ登録ボーナスarmony

R&D

Important matters regarding handling
ビットカジノ口コミ Returns Dividends
ビットカジノ登録ボーナス Policy
Recommended environment / Web accessibility

©2023 KYORIN Pharmaceutical Co., Ltd. All Rights Reserved.